Clinical and Molecular Hepatology (Clin Mol Hepatol, CMH)

4

A case of acute cholestatic hepatitis induced by Corydalis speciosa Max.

Hyun Seok Kang , Hyuk Soon Choi , Tae Jung Yun , Kwang Gyun Lee , Yeon Seok Seo , Jong Eun Yeon , Kwan Soo Byun , Soon Ho Um , Chang Duck Kim , Ho Sang Ryu

Clin Mol Hepatol. 2009;15(4):517-523. Published online December 31, 2009

DOI: https://doi.org/10.3350/kjhep.2009.15.4.517

View: 4994 Download: 55 Crossref: 11

Alfuzosin-induced Acute Liver Injury

Seok Yeon Kim, M.D., Byung-Ho Kim, M.D., Seok Ho Dong, M.D., Hyo Jong Kim, M.D., Young Woon Chang, M.D., Rin Chang, M.D., Yoon Wha Kim, M.D.

Clin Mol Hepatol. 2007;13(3):414-418. Published online September 20, 2007

DOI: https://doi.org/10.3350/kjhep.2007.13.3.414

View: 4399 Download: 35 Crossref: 8

3

The Survey for the Actual Condition of Drug Medication and Development of Health Care Cost Associated with Toxic Liver Injury in Korean; A Multicenter Study for the Detection and the Development of Nationwide Reporting System of Toxic Liver Injury

Tae Woo Yoo, M.D., Byung Ik Kim, M.D., Jin Bong Kim, M.D. Dong Joon Kim, M.D. Jae Woo Kim. Soon Koo Baik. Kwang Seok Kim, M.D. Gab Jin Cheon, M.D.

Clin Mol Hepatol. 2007;13(1):34-43. Published online January 1, 2000

View: 2608 Download: 28

4

Toxic Hepatitis Associated with Carp Juice Ingestion

Hye Suk Son , Guil Sun Kim , Seung Woo Lee , Sang Bum Kang , Jong Tae Back , Soon Woo Nam , Dong Soo Lee , Byung Min Ahn

Clin Mol Hepatol. 2006;12(1):103-106. Published online January 1, 1970

View: 3139 Download: 23

3

Clinical Experience of 48 Acute Toxic Hepatitis Patients

Jeong Chul Seo, M.D., Won Joong Jeon, M.D., Sung Soon Park, M.D., Seok Hyung Kim, M.D. Ki Man Lee, M.D., Hee Bok Chae, M.D., Seon Mee Park, M.D. and Sei Jin Youn, M.D.

Clin Mol Hepatol. 2006;12(1):74-81. Published online January 1, 1970

View: 3462 Download: 52

1

Acute Toxic Hepatitis: RUCAM Application to Drug-induced Liver Injury and Its Limitations

Byung Min Ahn

Clin Mol Hepatol. 2006;12(1):1-4. Published online January 1, 1970

View: 2729 Download: 33

1 |

Viewed By 5706	Prognostic value of ultra-low-pass whole-genome sequencing of circulating tumor DNA in hepatocellular carcinoma under systemic treatment
Viewed By 4993	MAFLD: How is it different from NAFLD?
Viewed By 4753	Assessing the performance of ChatGPT in answering questions regarding cirrhosis and hepatocellular carcinoma
Viewed By 3854	2022 KLCA-NCC Korea practice guidelines for the management of hepatocellular carcinoma
Viewed By 3848	Global incidence and prevalence of nonalcoholic fatty liver disease

Cited By 135	Assessing the performance of ChatGPT in answering questions regarding cirrhosis and hepatocellular carcinoma
Cited By 104	2022 KLCA-NCC Korea practice guidelines for the management of hepatocellular carcinoma
Cited By 82	Global incidence and prevalence of nonalcoholic fatty liver disease
Cited By 68	Forecasted 2040 global prevalence of nonalcoholic fatty liver disease using hierarchical bayesian approach
Cited By 57	MAFLD: How is it different from NAFLD?

Search